𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Monitoring of serum amylase levels during valproic acid therapy

✍ Scribed by James F. Bale Jr.; Patricia E. Gay; Jack A. Madsen

Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
223 KB
Volume
11
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Monitoring of viral levels during therap
Monitoring of viral levels during therapy of hepatitis C
✍ Gary L. Davis πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 793 KB

Alpha interferon therapy of chronic hepatitis C is typically accompanied by a biphasic decrease in hepatitis C virus (HCV) RNA levels: an initial rapid decline during the first 24 to 48 hours, and a second more gradual decline during the following weeks. The rate of second-phase decline correlates w

Patterns of circulating hepatitis B viru
Patterns of circulating hepatitis B virus serum nucleic acids during lamivudine therapy
✍ Wei Zhang; Hans JΓΆrg Hacker; Mehmet Tokus; Thomas Bock; Claus H. SchrΓΆder πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 115 KB

## Abstract We examined whether lamivudine treatment, in addition to the rapid decline of HBV serum DNA described in a large number of laboratories, causes changes in composition and amount of discernable circulating viral DNA and RNA. Nucleic acids were extracted from serial serum samples of a pat

The prognostic value of changes in serum
The prognostic value of changes in serum ferritin levels during therapy for hepatitis C virus infection
✍ Zvi Ackerman; Orit Pappo; Iddo Z. Ben-Dov πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 169 KB πŸ‘ 1 views

## Abstract An increase in serum ferritin levels during combined interferon–ribavirin treatment in chronic patients infected with hepatitis C virus (HCV) can occur. A study was conducted to determine whether observing the kinetics of serum ferritin levels during antiviral therapy, may assist in pre